ARTICLE | Politics, Policy & Law
Rhodium Group report suggests Congress focus on economic rather than military threats from China biotech
By Steve Usdin, Washington Editor
November 19, 2024 11:14 PM UTC
A report from an influential consulting company challenges the focus of the Biosecure Act by suggesting that lawmakers are targeting low-risk Chinese biotech companies and overlooking higher-priority threats posed by companies with close ties to the Chinese government.
Two of the companies that would be subject to sanctions if the Biosecure Act (H.R. 8333) is enacted in its current form, WuXi AppTec Co. Ltd. (Shanghai:603259; HKEX:2359) and WuXi Biologics Inc. (HKEX:2269), pose low risks, according to the Rhodium Group report “Chinese Biotech Companies: A Fundamental Risk Scorecard.”…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/654254/as-congress-considers-biosecure-report-says-wuxi-companies-low-risk